Skip to main content
SpringerLink
Log in

Radioimmunoscintigraphy of lymphoma with monoclonal antibodies

  • Chapter
Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias

Part of the book series: Cancer Treatment and Research ((CTAR,volume 38))

  • 59 Accesses

Abstract

Patients with histologically proven lymphoma must undergo an extensive pretreatment diagnostic evaluation. Such testing is important in the choice of therapy as well as in defining the prognosis. Staging examinations must be repeated at intervals in order to evaluate the response to treatment [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31:1860–1861, 1971.

    PubMed  CAS  Google Scholar 

  2. Chabner BA, Johnson RE, Young RC, et al: Sequential nonsurgical staging of non-Hodgkin’s lymphoma. Ann Med 85:149–154, 1976.

    CAS  Google Scholar 

  3. Bunn PA Jr, Huberman MS, Whang-Peng J, et al: Prospective staging evaluation of patients with cutaneous T-cell lymphomas: Demonstration of high frequency of extracu-taneous dissemination. Ann Med 3:223–230, 1980.

    Google Scholar 

  4. Bunn PA, Lamberg SI: Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:725–728, 1979.

    PubMed  Google Scholar 

  5. Hamlin J: Radiographic approach to the staging of lymphoma, including Hodgkins disease. In: JM Bennett (ed): Lymphoma, 1 Martinus Nihoff Publishers, 1981, pp 1, 177, 233.

    Google Scholar 

  6. Goldenberg DM, DeLand FH, Kim E, et al: Use of radiolabeled antibodies to carcinoem-bryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298:1384–1386. 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Kohler G, Milstein C: Continuous culture of fused cells secreting antibody of predefined specificity. Nature (London) 256:495–497. 1975.

    Article  CAS  Google Scholar 

  8. Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J: Radio-localization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 43:736–742, 1983.

    PubMed  CAS  Google Scholar 

  9. Halpern SE, Hagan PL, Garver PR, Koziol JA, Chen AWN, Frincke JM, Bartholomew RM, Davis GS, Adams TH: Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models. Cancer Res 43:5347–5355, 1983.

    PubMed  CAS  Google Scholar 

  10. Moshakis V, Mcllhinney RA, Raghavan D, Neville AM: Localization of human tumor xenografts after I.V. administration of radiolabeled monoclonal antibodies. Br J Cancer 44:91–99, 1981.

    Article  PubMed  CAS  Google Scholar 

  11. Pimm MV, Embleton MJ, Perkins AC, Price MR, Robins RA, Robinson GR, Baldwin RW: In vivo localization of anti-osteogenic sarcoma 79IT monoclonal antibody in osteogenic sarcoma xenografts. Int J Cancer 30:75–85, 1982.

    Article  PubMed  CAS  Google Scholar 

  12. Ghose T, Ferrone S, Imai K, Norvell ST, Luner SJ, Martin RH, Blair AH: Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody. J Natl Cancer Inst 69 (4):823–826, 1982.

    PubMed  CAS  Google Scholar 

  13. Beaumier PL, Larson SM, Krohn KA, Ferens JM, Nelp WB, Brown JP: Effects of iodinatin of p97 antigen-specific binding and in vivo tumor localization using monoclonal antibody fragments. J Nucl Med 24:116, 1982.

    Google Scholar 

  14. Mach JP, Carrel S, Forni M, et al: Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 5–10, 1980.

    Google Scholar 

  15. Sullivan DC, Silva JS, Cox CE, et al: Localization of 131I labeled goat and primate anti-carcinoembryonic antigen (CEA) antibodies in patients with cancer. Invest Radiol 17:350–355, 1982.

    Article  PubMed  CAS  Google Scholar 

  16. Ott RJ, Grey LJ, Zivanovic MA, Flower MA, Trott NG, Moshakis V, Coombes RC, Neville AM, Ormerod MG, Westwood JH, McCready VR: The limitations of the dual radionuclide substraction technique for the external detection of tumours by radioiodine-labelled antibodies. Br J Radiol 56:101–108, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Mach JP, Chatal JF, Lumbroso JD, et al: Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res 43:5593–5600, 1983.

    PubMed  CAS  Google Scholar 

  18. Scheinberg DA, Strand M, Gansow O: Tumor imaging with radioactive metal chelates conjugated to monoclonal antibody. Science 215:1511–1513, 1982.

    Article  PubMed  CAS  Google Scholar 

  19. Scheinberg DA, Strand M: Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice. Can Res 43:265–272, 1983.

    CAS  Google Scholar 

  20. Badger CC, Krohn KA, Peterson A, et al: Radiotherapy of murine lymphoma with 131I labeled anti-Thy 1.1 monoclonal antibody. Can Res 45:1536–1544, 1985.

    CAS  Google Scholar 

  21. Miller RA, Oseroff AR, Stratte PT, Levy R: Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood 62:988–995, 1983.

    PubMed  CAS  Google Scholar 

  22. Miller RA, Maloney DG, McKillop J, Levy R: In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood 58:78, 1981.

    PubMed  CAS  Google Scholar 

  23. Dillman RO, Sobol RE, Collins H, Beauregard J, Royston I: T101 monoclonal antibody therapy in chronic lymphocytic leukemia. In: Oettgen H, Mitchell M (eds): Hybridomas in

    Google Scholar 

  24. Cancer Diagnosis and Treatment, New York, Raven Press, 1982, pp 151–171.

    Google Scholar 

  25. Foon KA, Schroff RW, Bunn RA, Mayer D, Abrams PG, Fer MF, Ochs JJ, Bottino GC, Sherwin SA, Herberman RB, Oldham RK: Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia. Blood 64:1085–1094, 1984.

    PubMed  CAS  Google Scholar 

  26. Ritz J, Pensando JM, Sullan SE et al: Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood 58:141–152, 1981.

    PubMed  CAS  Google Scholar 

  27. Nadler LM, Stashenko P, Hardy R et al: Serotherapy of a patient with monoconal antibody directed against a human lymphoma-associated antigen. Cancer Res 40:3147–3154, 1980.

    PubMed  CAS  Google Scholar 

  28. Schroff RW, Foon KA, Beatty SM, Oldham RK, Morgan AC: Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy. Cancer Res 45: 879–885, 1985.

    PubMed  CAS  Google Scholar 

  29. Bunn PA, Carrasquillo JA, Keenan AM, et al: Imaging of T-cell lymphoma by radiolabeled monoclonal antibody. Lancet 2:1219–1211, 1984.

    Article  PubMed  Google Scholar 

  30. Carrasquillo JA, Bunn PA, Keenan AM et al: Radioimmunodetection of cutaneous T-cell lymphoma with 111In labeled T101 monoclonal antibody. N Engl J Med 315:673–680, 1986.

    Article  PubMed  CAS  Google Scholar 

  31. Royston I, Majda JA, Baird SM, et al: Human T-cell antigens defined by monoclonal antibodies: The 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 125:725–731, 1980.

    PubMed  CAS  Google Scholar 

  32. Dillman RO, Beauregard JC, Lea JW, et al: Chronic lymphocytic leukemia and other chronic lymphoid proliferation surface marker phenotypes and clinical correlations. J Clin Onco: 1:190–197, 1983.

    CAS  Google Scholar 

  33. Ledbetter JA, Frankel AE, Herzenberg LA, Herzenber, HA: Human Leu T-cell differentiation antigen: Quantitative expression on normal lymphoid cells and cell lines, In: GJ Hammerling, U Hammerling, JF Kearney (eds): Research Monographs in Immunology, volume 3, Monoclonal antibody and T-cell hybridoma, p 16–22, 1981.

    Google Scholar 

  34. Krejcarek GE, Tucker KL: Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Commun 77:581–585, 1977.

    Article  PubMed  CAS  Google Scholar 

  35. Bunn PA Jr, Edelson RL, Ford SS, Shackney SE: Patterns of cell proliferation and cell migration in the Sézary syndrome. Blood 57:452–463, 1981.

    PubMed  Google Scholar 

  36. Miller RA, Coleman CN, Fawcett HD, Hoppe RT, McDougall IR: Sézary syndrome: A model for migration of T-lymphocytes to skin. N Engl J Med 303:89–92, 1980.

    Article  PubMed  CAS  Google Scholar 

  37. Schroff RW, Klein RA, Farrell MM, Stevenson, HC: Enhancing effects of monocytes on modulation of a lymphocyte membrane antigen. J Immunol 133(4):1641–1648, 19.

    Google Scholar 

  38. Boven E, Lindmo T, Mitchell J, Bunn P: Selective cytotoxicity of 125I-labeled monoclonal antibody T101 in human malignant T cell lines. Blood 67:429–435, 1986.

    PubMed  CAS  Google Scholar 

  39. Carrasquillo JA, Mulshine JL, Bunn P, et al: Tumor imaging of 111In T101 monoclonal antibody is superior to 131I T101 in cutaneous T-cell lymphoma. J Nucl Med. in press.

    Google Scholar 

  40. Shawler DL, Miceli MC, Wormsley SB, Royston I, Dillman RO: Interaction of in vitro and in vivo antigenic modulation by the anti-human T-cell monoclonal antibody T101. Cancer Res 44:5921–5927, 1984.

    PubMed  CAS  Google Scholar 

  41. Thakur M, Segal AW, Louis WL et al: In–111 labeled cellular blood components: Mechanism of labeling and intracellular location in human neutrophils. J Nucl Med 18:1022–1026, 1977.

    PubMed  CAS  Google Scholar 

  42. Spies SM, Zimmer AM, Spies WG, et al: Initial experience with radioimmunodetection and therapy of cutaneous T-cell lymphoma using murine monoclonal antibodies (abstract). J of Nucl Med 27:903, 1986.

    Google Scholar 

  43. Weintstein JN, Parker RJ, Keenan AM et al: Monoclonal antibodies in the lymphatics: Toward the diagnosis and therapy of tumor metastases. Science 218:1334–1337, 1982.

    Article  Google Scholar 

  44. Weinstein JN, Steiler MA, Covell DG, et al: Use of monoclonal antibodies for diagnosis and therapy of tumor metastases in lymph node metastases of a solid tumor. Science 222: 423–426, 1986.

    Article  Google Scholar 

  45. Order SE, Bloomer WD, Kaplan JA, et al: Radionuclide immunoglobulin lymphangiography: A case report. Cancer 35:1487–1489, 1985.

    Article  Google Scholar 

  46. Deland FH, Kimm EE, Goldenberg DM: Lymphoscintigraphy with radionuclide-labeled antibodies to carcinoembryonic antigen. Cancer Res 40:2997–3000, 1980.

    PubMed  CAS  Google Scholar 

  47. Thompson CH, Lichtenstein M, Stacker SA, Leyden MJ, Salehi N, Andrews JT, McKenzie IF: Immunoscintigraphy for detection of lymph node metastases from breast cancer, Lancet 2(8414):1245–7, 1984.

    Article  PubMed  CAS  Google Scholar 

  48. Lotze MT, Carrasquillo JA, Weinstein JN, et al: Monoclonal antibody imaging of human melanoma: Radioimmunodetection by subcutaneous or systemic injection. Ann Surg, in press.

    Google Scholar 

  49. Keenan AM, Weinstein JN, Mulshine JL, et al: Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of Indium-Ill T101 monoclonal antibody. J Nucl Med 28:42–46, 1987.

    PubMed  CAS  Google Scholar 

  50. Carrasquillo JA, Krohn KA, Beaumier P, et al: Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treat Rep 68:317–318, 1984.

    PubMed  CAS  Google Scholar 

  51. Reynolds JC, Carrasquillo JA, Larson SM: Human anti-murine response following administration of radiolabeled monoclonal antibodies, J Nucl Med 26(227):55.

    Google Scholar 

  52. Pimm MV, Perkins AC, Armitage NC, Baldwin RW: The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med 26:1011–1023, 1985.

    PubMed  CAS  Google Scholar 

  53. Koprowski H, Herlyn D, Lubeck M, et al: Human anti-idiotype antibodies in cancer patients: Is the modulation of immune response benefitial for the patient? Proc Natl Acad Sci USA 81(1):216–219, 1984.

    Article  PubMed  CAS  Google Scholar 

  54. Epenetos AA, Snook D, Hooker G, Begent R, Durbin H, et al: Indium-Ill labelled monoclonal antibody to placental alkaline phosphatase in the detection of neoplasms of testis, ovary, and cervix. Lancet 2(8451):350–3, 1985.

    Article  PubMed  CAS  Google Scholar 

  55. Larson SM, Carrasquillo JA, McGuffin RW, et al: Use of 131I labeled, murine Fab against a high molecular weight antigen of human melanoma: Preliminary experience. Radiology 155:487–492, 1985.

    PubMed  CAS  Google Scholar 

  56. Larson SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Fereus JM, Graham MM, Hill LD, Beaumier PL, Hellstrom KE, Hellstrom I: Localization of 131I labeled p97 specific FAB fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72:2101–2114, 1983.

    Article  PubMed  CAS  Google Scholar 

  57. Buraggi GL, Callegaro L, Mariani G, et al: Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: Efficacy of whole immunoglobulin and its F(ab’)2 fragments. Cancer Res: 45(7):3378–87, 1985.

    PubMed  CAS  Google Scholar 

  58. Moldofsky PJ, Powe J, Mulhern CB, Hammond N, Sears HF, Gatenby RA, Steplewski Z, Koprowski H. Metastatic colon carcinoma detected with radiolabeled F(ab’)2 monoclonal antibody fragments. Radiology 149:549–555, 1984.

    Google Scholar 

  59. McConahey PJ, Dixon FJ: A method of trace iodination of proteins for immunologic studies. Int Arc Aller 29:185–189, 1966.

    Article  CAS  Google Scholar 

  60. Fraker PJ, Speck JC Jr: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro–3a, 6a-diphenylgly-coluril. Biochem Biophys Res Commun 80:849–857, 1978.

    Article  PubMed  CAS  Google Scholar 

  61. Epenetos AA, Shepherd J, Britton KE, et al: 123I radioiodinated antibody imaging of occult ovarian cancer. Cancer 55(5):984–7, 1985.

    Article  PubMed  CAS  Google Scholar 

  62. Pateisky N, Philippk, Burchel J, et al: Radioimmunodetection in patients with suspected ovarian cancer. J Nucl Med 26:1369–1376, 1985.

    PubMed  CAS  Google Scholar 

  63. Davies JO, Davies ER, Howe K, Jackson PC, et al: Radionuclide imaging ovarian tumors with 123I-labelled monolonal antibody (NDOG2) directed against placental alkaline phosphatase. Br J Obstel Gynaecol 1985. 92(3):277–86.

    Article  CAS  Google Scholar 

  64. Ell PJ, Khan O: Emission computerized tomography: Clinical applications. Semin Nucl Med 11:50–60, 1981.

    Article  PubMed  CAS  Google Scholar 

  65. Berche C, Mach JP, Lumbroso JD, et al: Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: First clinical results using radiolabeled monoclonal antibodies against carcinoembryonic antigen. Br Med J 285:1447–1451, 1982.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Jorge A. Carrasquillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven M. Larson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Rochester Cancer Center, Rochester, New York, 14642, USA

    John M. Bennett

  2. Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, 48109, USA

    Kenneth A. Foon

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers

About this chapter

Cite this chapter

Carrasquillo, J.A., Larson, S.M. (1988). Radioimmunoscintigraphy of lymphoma with monoclonal antibodies. In: Bennett, J.M., Foon, K.A. (eds) Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias. Cancer Treatment and Research, vol 38. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1713-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1713-5_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8965-4

  • Online ISBN: 978-1-4613-1713-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation